NasdaqGS:INSMBiotechs
Insmed (INSM) Gains On Brinsupri Optimism, Is The Stock Still A Bargain?
Understanding the Recent Shift in Insmed’s Index Inclusion
Insmed (INSM) is drawing fresh attention after being dropped from several Russell value and growth benchmarks in late June, even as investors focus on its recently FDA approved respiratory therapy Brinsupri.
Index removals can influence trading volumes and ownership patterns because many funds track or reference these benchmarks when deciding what to hold. For you, the key question is whether these technical index changes alter the...